THE IMPORTANCE OF THE PERFORMANCE OF THE PHARMACOVIGILANCE SERVICE IN PROMOTING THE SAFE USE OF MEDICINES

Abstract

Background: Pharmacovigilance occupies a prominent place after the event known as “the Thalidomide disaster”; several babies were born with malformations resulting from the teratogenic action of the drug in question, but before that, there had already been occurrences of damage in patients associated with the use of drugs. Objective: Promote a reflection on the importance of the performance of the pharmacovigilance service in the use of medicines. Methods: The study consists of preparing a prospective literature review on the most recent publications that address theoretical and practical concepts related to pharmacovigilance services in promoting the safe use of medications. Results: Risks will always exist with each new drug substance introduced on the market, but it is necessary to carefully evaluate each secondary outcome to identify the implementation of barriers and, thus, incorporate improvements in the processes that reduce negative events for the individuals assisted. Conclusion: The continuous development of health information technology can significantly improve patient safety, including innovative solutions, such as multiple strategies that prioritize integration through synergy, with the involvement of scientists, health professionals, and patients, whenever possible.